Anjana Pillai to Immunotherapy
This is a "connection" page, showing publications Anjana Pillai has written about Immunotherapy.
Connection Strength
0.078
-
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. J Hepatol. 2024 Mar; 80(3):431-442.
Score: 0.040
-
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):202-213.
Score: 0.037